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Abstract
Background: HPV infection in women from developing countries is an important public health
problem. Therefore, we sought to determine the prevalences of HPV infection and HPV genotypes
in a female population of Durango City, Mexico. Also to determine whether any socio-demographic
characteristic from the women associated with HPV infection exists.
Methods: Four hundred and ninety eight women seeking cervical Papanicolaou examination in
three public Health Centers were examined for HPV infection. All women were tested for HPV
DNA PCR by using HPV universal primers. In addition, all positive HPV DNA PCR samples were
further analyzed for genotyping of HPV genotype 16, 18 and 33. Socio-demographic characteristics
from each participant were also obtained.
Results: Twenty-four out of four hundred and ninety-eight (4.8%) women were found infected by
HPV. HPV genotype 16 was found in 18 out of the 24 (75%) infected women. Two of them were
also coinfected by HPV genotype 18 (8.3%). In the rest 6 PCR positive women, genotyping for HPV
genotypes 16, 18 and 33 were negative.
Conclusion: The prevalence of HPV in women of Durango City is low; however, most infected
women have high risk HPV genotype. The women who were studied showed low frequency of risk
factors for HPV infection and this may explain the low prevalence of HPV infection. The high
frequency of high risk HPV genotypes observed might explain the high rate of mortality for cervical
cancer in our region.
Background
Human papillomavirus virus (HPV) is the main causal
factor of cervical cancer [1]. This virus is sexually transmit-
ted and the male is the carrier. More than 100 HPV geno-
types have been described and 20 of them have been
associated with cervical cancer. In an international study
performed in 1995 and using molecular biology tech-
niques, HPV was found in more than 93% of cervical can-
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cer specimens [2]. In addition, the researchers found that
HPV genotypes 16, 18, 31 and 45 were found in 49.2%,
11.7%, 5% and 8%, respectively. HPV genotype 16 was
more frequently observed in squamous carcinoma while
genotype 18 was in adenocarcinoma. Prevalence of HPV
infection in women varies substantially among countries
and according to age and life style. For instance, in the
United States 64% of teenagers studied were found
infected and 77% of them were infected by high risk HPV
genotypes [3]. Similarly, Korean prostitutes [4] and
women with pre-neoplastic and neoplastic cervical
lesions from the Federal District of Brazil [5] have shown
prevalences as high as 47% and 43% of HPV infection,
respectively. In contrast, prevalences as low as 3% to 14%
have been found in married women from Barcelona,
Spain [6], Amazonian women from Bolivia [7], and post-
menopausal women of Iowa City [8]. In Mexico, cervical
carcinoma is the most frequent cancer. In a study per-
formed in the year 2000, as much as 20,292 new cases
were reported [9]. HPV was identified as the most impor-
tant agent associated with cervical intraepithelial neopla-
sia [10]. In addition, HPV types 16, 18 and 45 have been
found in cervical tumors from the Mexican population
[11,12]. Little is known about the molecular epidemiol-
ogy of HPV in Durango State. Therefore, we performed a
descriptive and cross sectional study in order to determine
the prevalence of HPV infection, and HPV genotypes in
women of Durango City, Mexico as well as to know
whether any characteristic of the women is associated
with HPV infection.
Methods
Study population
We have studied 498 women seeking for cervical Papani-
colaou examination and attending three public health
centers of Durango City, Mexico. One hundred and sixty
six women from each health center were included in the
study. Health centers were a University outpatient clinic
(Institute for Scientific Research), a hospital of the Insti-
tuto Mexicano del Seguro Social (IMSS), and a hospital of
the State Health Office (Secretaria de Salud). All 498 par-
ticipants were enrolled consecutively from July to Decem-
ber 2003.
Socio-demographic data
Socio-demographic data including age, birth place, resi-
dence place, marital status, occupation, age at start of
Representative gel of HPV genotyping Figure 1
Representative gel of HPV genotyping. Left column shows a 
100 bp ladder. Central and right columns show two HPV 
type 16 positive samples.
Table 1: Overall prevalence of cervical lesions in women of three public health centers.
Cytological diagnosis SSa IMSSb IICc Total p value
No. % No. % No. % No. %
Low-grade intraepithelial lesion 6 3.6 0 0 1 0.6 7 1.4 NSd
High-grade intraepithelial lesion 1 0.6 2 1.2 0 0 3 0.6 NS
Invasive carcinoma 0 0 1 0.6 0 0 1 0.2 NS
T o t a l 74 . 231 . 810 . 6 1 1 2 . 2 0 . 0 2 1
aSS: Secretaria de Salud.
bIMSS: Instituto Mexicano del Seguro Social.
cIIC: Instituto de Investigación Científica.
dNS: not statistically significant.BMC Infectious Diseases 2006, 6:27 http://www.biomedcentral.com/1471-2334/6/27
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active sexual activity, number of sexual partners, use of
condom, and history of smoking from all 498 women
studied were obtained.
Cervical papanicolaou cytology
A cervical smear was obtained from each participant by
using Ayre spatula and cytology brush. Papanicolaou
smears were evaluated according to the Bethesda diagno-
sis criteria [13].
HPV DNA PCR and HPV genotyping
A second cervical specimen was obtained with the aid of a
cervical brush for HPV DNA PCR and HPV genotyping.
DNA extraction was performed by using DNAzol (Invitro-
gen Inc. Carlsbad. CA, USA). With this method, good
quality DNA was obtained inferred by the MW>20 kb for
the genomic human DNA analyzed by means of 1% agar-
ose electrophoresis, stained with ethidium bromide. In
addition, the latter was confirmed by obtaining positive
results for beta globin in all samples. HPV DNA PCR was
carried out by using MY09/11 primers as described else-
where [14]. The MY-PCR system has shown a sensitivity of
90% in samples containing multiple HPV types [15]. Con-
centrations of Mg++, primers, Taq polimerase, dNTP,
tetramethylene sulfoxide, and DNA in each 50 µl reaction
were 2 mM, 0.2 µM, 2 units, 0.2 mM, 2%, and 2 µg. DNA
concentration used was determined based on preliminary
analysis of DNA concentrations. Positive results were
obtained with as low DNA concentration as 5 ngr. Thirty
nine cycles of 94°C for one minute (denaturation), 55°C
for two minutes (annealing), and 72°C for two and a half
minutes (extension) were performed. PCR products were
run in 2% agarose electrophoresis, stained with ethidium
bromide, and visualized with the aid of UV light. Positive
HPV DNA PCR samples were further analyzed for HPV
genotyping. The presence of 3 genotypes were explored,
namely HPV genotypes 16, 18 and 33. HPV genotyping
PCR was carried out by using specific primers (Takara
Mirus Bio Corp. Madison WI, USA) for amplification of
the sequence containing E6 region of HPV 16, 18 and 33.
The sequences were: forward common, 5'AAG-
GGCGTAACCGAAATCGGT3'; reverse 16, 5'GTTTGCA-
GCTCTGTGCATA3'; 18, 5'GTGTTCAGTTCCGTGCACA3',
33, 5'GTCTCCAATGCTTGGCACA3'. The amplified prod-
ucts correspond to 140 bp for HPV 16 and 18, and 141 bp
for HPV 33. Cycling temperatures for HPV genotyping
were as follows: forty five cycles of 95°C for one minute
(denaturation), 57°C for one minute (annealing), and
72°C for one minute (extension).
Ethical aspects
This study was approved by the institutional ethical com-
mittee. The purpose and procedures of the study were
explained to all participants, and a written informed con-
sent was obtained from all of them.
Table 3: Distribution of HPV genotypes in 24 HPV PCR positive women of three public health centers.
HPV genotype SSa IMSSb IICc Total p value
No. Proportion No. Proportion No. Proportion No. Proportion
16 10 0.556 2 1 4 1 16 0.667
16 and 18 2 0.111 0 0 0 0 2 0.83
Negative for HPV 16, 18 and 33 6 0.333 0 0 0 0 6 0.25 NSd
Total 18 0.75 2 0.83 4 0.167 24 1
aSS: Secretaria de Salud.
bIMSS: Instituto Mexicano del Seguro Social.
cIIC: Instituto de Investigación Científica.
dNS: not statistically significant.
Table 2: Overall prevalence of HPV infection in women of three public health centers.
HPV PCR SSa IMSSb IICc Total p value
N o .%N o .%N o .%N o .%
Positive 18 10.8 2 1.2 4 2.4 24 4.8 0.001
Negative 148 89.2 164 98.8 162 97.6 474 95.2 NSd
Total 166 100 166 100 166 100 498 100
aSS: Secretaria de Salud.
bIMSS: Instituto Mexicano del Seguro Social.
cIIC: Instituto de Investigación Científica.
dNS: not statistically significant.BMC Infectious Diseases 2006, 6:27 http://www.biomedcentral.com/1471-2334/6/27
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Statistical analysis
Results were analyzed with the aid of the software Epi Info
6. To assess the association between the characteristics of
the subjects and the infection, the crude odds ratio with a
95% exact confidence interval was used. In addition, com-
parison of the frequencies between groups was performed
by the χ2 test. A level of P < 0.05 was considered signifi-
cant.
Results
Socio-demographic data
Most (87%) women were born in Durango State, and
37% were born in Durango City. All 498 women had a
residence in Durango City. The mean age was 39 years
(range: 20 to 72 years). Their occupations were: 60%
housewives, 16.8% professionals, 16.4% employees,
4.2% factory workers, 1% students, and 0.7% other activ-
ities. Their marital status included 70% married, 3.8%
widowed, 12% never married, 8% living together, and 6%
divorced. History of smoking was present in 18% of the
women. The mean age at start of active sexual activity was
20 years (range: 13 to 37). The mean number of sexual
partners was 1.8 (range: 1 to 20), and 18% used condom
during intercourse.
Cervical papanicolaou cytology
Eleven (2.2%) out of the 498 samples showed abnormal-
ities in the Papanicolaou examination. Table 1 shows the
results of the cytological examination in women of the
three public health centers studied.
HPV DNA PCR and HPV genotyping
Women found infected by HPV were 24 out of 498
(4.8%). HPV genotype 16 was found in 18 out of the 24
(75%) infected women. Two of them (8.3%) were also
infected by HPV genotype 18. While six out of the 24 HPV
DNA PCR positive women showed negative results in PCR
for genotyping of HPV genotypes 16, 18 and 33. A repre-
sentative gel obtained in HPV genotyping is shown in Fig-
ure 1. Tables 2 and 3 show the results of the HPV DNA
PCR and the distribution of HPV genotypes in the three
public health centers studied, respectively. Table 4 shows
a correlation of HPV genotypes and cervical lesions
observed by Papanicolaou cytology.
Discussion
In this study, we found a 4.8% prevalence of HPV infec-
tion in women seeking cervical Papanicolaou examina-
tion of Durango City, Mexico. This prevalence is lower
than those reported in other regions of Mexico and the
majority of those reported abroad. In two previous Mexi-
can studies, prevalences of 14% and 15% were found
[16,17]. While in a Nigerian study [18] a prevalence of
26.3% was found. The prevalence found in the present
study is similar to those found in a Spanish study [6] and
a Bolivian study [7] where 3% and 5.2% of women were
infected, respectively. The lower prevalence found in our
study than those reported elsewhere might be explained
by differences in the characteristics of the study popula-
tion. Nevertheless, when the prevalence of HPV infection
in each health center is evaluated independently, the 10%
prevalence of HPV infection in women attending the hos-
pital of the State Health Office is closer to that reported in
other Mexican States [16,17,19]. Women attending this
hospital have a lower socioeconomic status than those
attending the other health centers explored. In addition,
those women attending the hospital with the lower prev-
alence (IMSS) were older than those of the other two
health centers. This finding agrees with the observation
that prevalence of HPV infection decreases with age. In
women from Flanders with abnormal cytology, preva-
lences of 82% at age 22, 60% at age 47, and 52% at age 65
were found [20]. Also in our study, we found a predomi-
nant HPV genotype 16 infection. This is remarkable, since
HPV genotype 16 infection is considered of high risk for
cervical carcinoma [1,21]. This finding might explain why
morbidity and mortality by HPV have shown irregular dis-
tribution in Mexican States. In the northern Durango
State, median morbidity rates but high mortality rates
have been reported [9], suggesting that our women popu-
Table 4: Correlation of HPV genotypes and cytology results in 11 women with cervical lesions.
HPV genotype LSILa HSILb ICc Total p value
No. Proportion No. Proportion No. Proportion No. Proportion
1 6 20 . 2 8 620 . 6 6 71 1 50 . 4 5 4N S d
16 and 18 1 142 1 0.333 0 0 2 0.182 NSd
3 3 00000000N S d
P C R  p o s i t i v e  b u t  n e g a t i v e  f o r  g e n o t y p i n g2 0 . 2 8 6 00002 0 . 1 8 2 N S d
P C R  n e g a t i v e 2 0 . 2 8 6 00002 0 . 1 8 2 N S d
Total 7 0.636 3 0.273 1 0.91 11 1 0.021
aLow-grade intraepithelial lesion.
bHigh-grade intraepithelial lesion.
cInvasive carcinoma.
dNS: not statistically significant.BMC Infectious Diseases 2006, 6:27 http://www.biomedcentral.com/1471-2334/6/27
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lation has higher mortality rate than that from other
regions because of the high prevalence of HPV genotype
16 infection. Since 75% of HPV infected women in
Durango city were infected by genotype 16, we remark the
need of genotyping testing in a regular basis in order to
reduce the risk for cervical carcinoma. We were unable to
determine the HPV genotype in 6 (25%) out of the 24
HPV DNA PCR positive samples. We have explored only
the presence of 3 HPV genotypes (16, 18 and 33) because
these genotypes are considered as high risk for cervical car-
cinoma and more likely to be found. The high number of
HPV genotypes makes our PCR approach unpractical for
detection of all genotypes. However, further studies may
clarify what other HPV genotypes are circulating in our
region. On the other hand, PCR was a better methodology
for detecting HPV infection than Papanicolaou examina-
tion. In this study, Papanicolaou cytology detected only 2
out of the 24 HPV infections. This finding stresses the
need of using molecular methods to improve the detec-
tion rate. High risk HPV genotypes 16 and 18 were more
frequently observed in high-grade intraepithelial lesions
and invasive carcinoma. These results agree with the
reported association of these genotypes with malignancy
[1,18,22]. Results indicate that PCR of cervix specimens
for detecting HPV infection and HPV genotyping of high
risk HPV genotypes is highly recommended.
Conclusion
We concluded that prevalence of HPV infection in women
seeking cervical Papanicolaou examination in Durango
City, Mexico was low. However, the high risk HPV geno-
type 16 is responsible for the majority of infections.
Women studied showed low frequency of risk factors for
HPV infection and this may explain the low prevalence of
HPV infection. The high frequency of high risk HPV gen-
otypes observed might explain the high rate of mortality
for cervical cancer in our region.
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